Drug Eluting Stent Market Report 2026
Download Free Sample Buy Now
Drug Eluting Stent Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Drug Eluting Stent Market Report 2026

Global Outlook – By Product (Polymer-Based, Polymer-Free), By Drug (Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, Other Drugs), By Scaffold (Cobalt-Chromium, Platinum-Chromium, Nitinol, Biodegradable, Other Scaffolds), By Application (Coronary Diseases, Peripheral Vascular Diseases), By End-User (Hospitals, Specialty Clinic) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Drug Eluting Stent Market Overview

• Drug Eluting Stent market size has reached to $8.26 billion in 2025

• Expected to grow to $11.7 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%

• Growth Driver: Impact Of Coronary Heart Disease On Drug-Eluting Stent Market

• Market Trend: Innovation In Advanced Drug-Eluting Coronary Stents

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Drug Eluting Stent Market?

A drug-eluting stent (DES) is a medical device used in the treatment of coronary artery disease (CAD). It is a small, mesh-like tube typically made of metal that is inserted into narrowed or blocked coronary arteries during a procedure called percutaneous coronary intervention (PCI) or angioplasty.

The main product types of drug eluting stents are polymer-based and polymer-free. Polymer-based drug-eluting stents (DES) are stents coated with a thin polymer layer that contains the drug(s) to be delivered to the arterial wall. The drug types include sirolimus, paclitaxel, zotarolimus, everolimus, biolimus, others with scaffolds such as cobalt-chromium, platinum-chromium, nitinol, biodegradable, and others used in applications such as coronary diseases and peripheral vascular disease by end-users such as hospitals and specialty clinics.

Drug Eluting Stent market report bar graph

What Is The Drug Eluting Stent Market Size and Share 2026?

The drug eluting stent market size has grown strongly in recent years. It will grow from $8.26 billion in 2025 to $8.94 billion in 2026 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to increasing prevalence of coronary artery disease, growth in percutaneous coronary intervention procedures, rising incidence of lifestyle-related cardiovascular conditions, expansion of cardiac catheterization labs, improved clinical outcomes compared to bare-metal stents.

What Is The Drug Eluting Stent Market Growth Forecast?

The drug eluting stent market size is expected to see strong growth in the next few years. It will grow to $11.7 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to growing aging population, increasing demand for minimally invasive cardiac treatments, rising awareness of advanced stent technologies, expansion of specialty cardiac clinics, increasing healthcare expenditure on cardiovascular care. Major trends in the forecast period include rising adoption of biodegradable polymer stents, growing preference for polymer-free drug-eluting stents, increasing use in complex coronary interventions, shift toward long-term restenosis prevention, rising demand for improved drug release control.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Drug Eluting Stent Market Segmentation

1) By Product: Polymer-Based, Polymer-Free

2) By Drug: Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, Other Drugs

3) By Scaffold: Cobalt-Chromium, Platinum-Chromium, Nitinol, Biodegradable, Other Scaffolds

4) By Application: Coronary Diseases, Peripheral Vascular Diseases

5) By End-User: Hospitals, Specialty Clinics

Subsegments:

1) By Polymer-Based: Durable Polymer Drug-Eluting Stents, Biodegradable Polymer Drug-Eluting Stents

2) By Polymer-Free: Bare-Metal Stents With Drug Coating, Other Polymer-Free Drug-Eluting Stents

What Is The Driver Of The Drug Eluting Stent Market?

The rising burden of coronary heart disease is expected to propel the growth of the drug-eluting stent market going forward. Coronary heart disease (CHD) is a condition where the coronary arteries become narrowed or blocked due to plaque buildup, potentially leading to severe complications such as a heart attack or chest pain. Coronary heart disease is increasing due to sedentary lifestyles, poor diets, aging populations, and heightened awareness. Drug-eluting stents (DES) benefit coronary heart disease by effectively opening narrowed or blocked coronary arteries and releasing medication that helps prevent re-narrowing (restenosis) of the artery. For instance, in August 2025, according to the National Center for Biotechnology Information, a US-based governmental agency, between 2025 and 2050, cardiovascular disease is projected to rise significantly, with prevalence increasing by 90.0%, crude mortality by 73.4%, and crude DALYs by 54.7%, leading to an estimated 35.6 million cardiovascular deaths in 2050, up from 20.5 million in 2025. The rising burden of coronary heart disease is expected to propel the growth of the drug-eluting stench market.

Key Players In The Global Drug Eluting Stent Market

Major companies operating in the drug eluting stent market are Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Terumo Corporation, BIOTRONIK SE & Co KG, Biosensors International Group Ltd, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Meril Life Sciences Pvt Ltd, Sahajanand Medical Technologies Pvt Ltd, Alvimedica Medical Technologies, Balton Sp z oo, Cordis (Cardinal Health) DES Manufacturing, Shandong JW Medical Systems Ltd, Sino Medical Sciences Technology Inc, STENTYS SA, Relisys Medical Devices Ltd, Translumina GmbH, Eurocor GmbH, Elixir Medical Corporation

Global Drug Eluting Stent Market Trends and Insights

Major companies operating in the drug eluting stent market are focusing on developing innovative products, such as low profile, high flexibility stents, to improve deliverability in complex coronary anatomies and enhance patient outcomes. A low-profile, high-flexibility stent refers to a drug eluting stent designed with a reduced crossing profile and enhanced flexibility, allowing it to navigate narrow, tortuous, or calcified coronary arteries more easily while maintaining effective drug delivery to prevent restenosis. For instance, in May 2024, Abbott Laboratories, a U.S.-based global healthcare company, launched the XIENCE Sierra Everolimus Eluting Coronary Stent System in India. The XIENCE Sierra features a novel stent design offering best in class deliverability, with significantly reduced crossing force when compared to competitors. It also includes a thinner balloon and an optimized MULTI LINK structure that enhances flexibility, while its high longitudinal strength ensures scaffold stability and resistance to deformation. Additionally, it offers a wide expansion range, allowing precise treatment even when vessel diameters vary markedly along the lesion—enabling interventional cardiologists to treat complex, calcified, or difficult-to-reach lesions with better precision and safety.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Drug Eluting Stent Market?

In October 2023, Cordis, a US-based developer and manufacturer of interventional vascular medical devices, acquired MedAlliance for an undisclosed amount. The acquisition aims to advance Cordis' legacy of cardiovascular innovation and expand its product portfolio in the coronary and peripheral vascular markets. M.A. Med Alliance SA is a Switzerland-based medical device manufacturer and distributor specializing in drug-eluting stents.

Regional Outlook

North America was the largest region in the drug-eluting stent market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Drug Eluting Stent Market?

The drug eluting stent market consists of revenues earned by entities by providing services such as pre-procedural assessment, procedural intervention, intraoperative monitoring, post-procedural care, and patient education. The market value includes the value of related goods sold by the service provider or included within the service offering. The drug eluting stenting market also includes sales of products including guide wires, angioplasty equipment, intravascular imaging systems, hemostasis devices, and diagnostic tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Drug Eluting Stent Market Report 2026?

The drug eluting stent market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the drug eluting stent industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Drug Eluting Stent Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $8.94 billion
Revenue Forecast In 2035 $11.7 billion
Growth Rate CAGR of 8.2% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Product, Drug, Scaffold, Application, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Terumo Corporation, BIOTRONIK SE & Co KG, Biosensors International Group Ltd, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Meril Life Sciences Pvt Ltd, Sahajanand Medical Technologies Pvt Ltd, Alvimedica Medical Technologies, Balton Sp z oo, Cordis (Cardinal Health) DES Manufacturing, Shandong JW Medical Systems Ltd, Sino Medical Sciences Technology Inc, STENTYS SA, Relisys Medical Devices Ltd, Translumina GmbH, Eurocor GmbH, Elixir Medical Corporation
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Drug Eluting Stent Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Drug Eluting Stent Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Drug Eluting Stent Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Drug Eluting Stent Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Industry 4.0 & Intelligent Manufacturing

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Rising Adoption Of Biodegradable Polymer Stents

4.2.2 Growing Preference For Polymer-Free Drug-Eluting Stents

4.2.3 Increasing Use In Complex Coronary Interventions

4.2.4 Shift Toward Long-Term Restenosis Prevention

4.2.5 Rising Demand For Improved Drug Release Control

5. Drug Eluting Stent Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Cardiac Catheterization Laboratories

5.4 Ambulatory Cardiac Care Centers

5.5 Tertiary Care Cardiology Centers

6. Drug Eluting Stent Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Drug Eluting Stent Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Drug Eluting Stent PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Drug Eluting Stent Market Size, Comparisons And Growth Rate Analysis

7.3. Global Drug Eluting Stent Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Drug Eluting Stent Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Drug Eluting Stent Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Drug Eluting Stent Market Segmentation

9.1. Global Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Polymer-Based, Polymer-Free

9.2. Global Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, Other Drugs

9.3. Global Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cobalt-Chromium, Platinum-Chromium, Nitinol, Biodegradable, Other Scaffolds

9.4. Global Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Coronary Diseases, Peripheral Vascular Diseases

9.5. Global Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinic

9.6. Global Drug Eluting Stent Market, Sub-Segmentation Of Polymer-Based, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Durable Polymer Drug-Eluting Stents, Biodegradable Polymer Drug-Eluting Stents

9.7. Global Drug Eluting Stent Market, Sub-Segmentation Of Polymer-Free, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Bare-Metal Stents With Drug Coating, Other Polymer-Free Drug-Eluting Stents

10. Drug Eluting Stent Market Regional And Country Analysis

10.1. Global Drug Eluting Stent Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Drug Eluting Stent Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Drug Eluting Stent Market

11.1. Asia-Pacific Drug Eluting Stent Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Drug Eluting Stent Market, Segmentation By Product, Segmentation By Drug, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Drug Eluting Stent Market

12.1. China Drug Eluting Stent Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Drug Eluting Stent Market, Segmentation By Product, Segmentation By Drug, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Drug Eluting Stent Market

13.1. India Drug Eluting Stent Market, Segmentation By Product, Segmentation By Drug, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Drug Eluting Stent Market

14.1. Japan Drug Eluting Stent Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Drug Eluting Stent Market, Segmentation By Product, Segmentation By Drug, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Drug Eluting Stent Market

15.1. Australia Drug Eluting Stent Market, Segmentation By Product, Segmentation By Drug, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Drug Eluting Stent Market

16.1. Indonesia Drug Eluting Stent Market, Segmentation By Product, Segmentation By Drug, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Drug Eluting Stent Market

17.1. South Korea Drug Eluting Stent Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Drug Eluting Stent Market, Segmentation By Product, Segmentation By Drug, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Drug Eluting Stent Market

18.1. Taiwan Drug Eluting Stent Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Drug Eluting Stent Market, Segmentation By Product, Segmentation By Drug, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Drug Eluting Stent Market

19.1. South East Asia Drug Eluting Stent Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Drug Eluting Stent Market, Segmentation By Product, Segmentation By Drug, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Drug Eluting Stent Market

20.1. Western Europe Drug Eluting Stent Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Drug Eluting Stent Market, Segmentation By Product, Segmentation By Drug, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Drug Eluting Stent Market

21.1. UK Drug Eluting Stent Market, Segmentation By Product, Segmentation By Drug, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Drug Eluting Stent Market

22.1. Germany Drug Eluting Stent Market, Segmentation By Product, Segmentation By Drug, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Drug Eluting Stent Market

23.1. France Drug Eluting Stent Market, Segmentation By Product, Segmentation By Drug, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Drug Eluting Stent Market

24.1. Italy Drug Eluting Stent Market, Segmentation By Product, Segmentation By Drug, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Drug Eluting Stent Market

25.1. Spain Drug Eluting Stent Market, Segmentation By Product, Segmentation By Drug, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Drug Eluting Stent Market

26.1. Eastern Europe Drug Eluting Stent Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Drug Eluting Stent Market, Segmentation By Product, Segmentation By Drug, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Drug Eluting Stent Market

27.1. Russia Drug Eluting Stent Market, Segmentation By Product, Segmentation By Drug, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Drug Eluting Stent Market

28.1. North America Drug Eluting Stent Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Drug Eluting Stent Market, Segmentation By Product, Segmentation By Drug, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Drug Eluting Stent Market

29.1. USA Drug Eluting Stent Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Drug Eluting Stent Market, Segmentation By Product, Segmentation By Drug, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Drug Eluting Stent Market

30.1. Canada Drug Eluting Stent Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Drug Eluting Stent Market, Segmentation By Product, Segmentation By Drug, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Drug Eluting Stent Market

31.1. South America Drug Eluting Stent Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Drug Eluting Stent Market, Segmentation By Product, Segmentation By Drug, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Drug Eluting Stent Market

32.1. Brazil Drug Eluting Stent Market, Segmentation By Product, Segmentation By Drug, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Drug Eluting Stent Market

33.1. Middle East Drug Eluting Stent Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Drug Eluting Stent Market, Segmentation By Product, Segmentation By Drug, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Drug Eluting Stent Market

34.1. Africa Drug Eluting Stent Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Drug Eluting Stent Market, Segmentation By Product, Segmentation By Drug, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Drug Eluting Stent Market Regulatory and Investment Landscape

36. Drug Eluting Stent Market Competitive Landscape And Company Profiles

36.1. Drug Eluting Stent Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Drug Eluting Stent Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Drug Eluting Stent Market Company Profiles

36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.5. BIOTRONIK SE & Co KG Overview, Products and Services, Strategy and Financial Analysis

37. Drug Eluting Stent Market Other Major And Innovative Companies

Biosensors International Group Ltd, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Meril Life Sciences Pvt Ltd, Sahajanand Medical Technologies Pvt Ltd, Alvimedica Medical Technologies, Balton Sp z oo, Cordis (Cardinal Health) DES Manufacturing, Shandong JW Medical Systems Ltd, Sino Medical Sciences Technology Inc, STENTYS SA, Relisys Medical Devices Ltd, Translumina GmbH, Eurocor GmbH, Elixir Medical Corporation

38. Global Drug Eluting Stent Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Drug Eluting Stent Market

40. Drug Eluting Stent Market High Potential Countries, Segments and Strategies

40.1 Drug Eluting Stent Market In 2030 - Countries Offering Most New Opportunities

40.2 Drug Eluting Stent Market In 2030 - Segments Offering Most New Opportunities

40.3 Drug Eluting Stent Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Drug Eluting Stent Market, Overview Of Key Products - Product Examples
  • Table 2: Global Drug Eluting Stent Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Drug Eluting Stent Market, Supply Chain Analysis
  • Table 4: Global Drug Eluting Stent Market, Major Raw Material Providers
  • Table 5: Global Drug Eluting Stent Market, Major Resource Providers
  • Table 6: Global Drug Eluting Stent Market, Major Manufacturers (Suppliers)
  • Table 7: Global Drug Eluting Stent Market, Major Distributors And Channel Partners
  • Table 8: Global Drug Eluting Stent Market, Key Technologies & Future Trends
  • Table 9: Global Drug Eluting Stent Market, Major Trends
  • Table 10: Global Drug Eluting Stent Market, Major End Users
  • Table 11: Global Drug Eluting Stent Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Drug Eluting Stent Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Drug Eluting Stent Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Drug Eluting Stent Market - TAM, US$ Billion, 2025
  • Table 15: Global Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Drug Eluting Stent Market, Sub-Segmentation Of Polymer-Based, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Drug Eluting Stent Market, Sub-Segmentation Of Polymer-Free, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Drug Eluting Stent Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Drug Eluting Stent Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global Drug Eluting Stent Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global Drug Eluting Stent Market - Company Scoring Matrix
  • Table 98: Abbott Laboratories Financial Performance
  • Table 99: Boston Scientific Corporation Financial Performance
  • Table 100: Medtronic plc Financial Performance
  • Table 101: Terumo Corporation Financial Performance
  • Table 102: BIOTRONIK SE & Co KG Financial Performance
  • Table 103: Global Drug Eluting Stent Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global Drug Eluting Stent Market, Competitive Dashboard
  • Table 105: Global Drug Eluting Stent Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, Drug Eluting Stent Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Table 107: Global, Drug Eluting Stent Market Size Gain ($ Billion), Segmentation By Drug, 2025 – 2030
  • Table 108: Global, Drug Eluting Stent Market Size Gain ($ Billion), Segmentation By Scaffold, 2025 – 2030

List Of Figures

    Figure 1: Global Drug Eluting Stent Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Drug Eluting Stent Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Drug Eluting Stent Market, Supply Chain Analysis
  • Figure 4: Global Drug Eluting Stent Market, Major Raw Material Providers
  • Figure 5: Global Drug Eluting Stent Market, Major Resource Providers
  • Figure 6: Global Drug Eluting Stent Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Drug Eluting Stent Market, Major Distributors And Channel Partners
  • Figure 8: Global Drug Eluting Stent Market, Key Technologies & Future Trends
  • Figure 9: Global Drug Eluting Stent Market, Major Trends
  • Figure 10: Global Drug Eluting Stent Market, Major End Users
  • Figure 11: Global Drug Eluting Stent Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Drug Eluting Stent Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Drug Eluting Stent Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Drug Eluting Stent Market - TAM, US$ Billion, 2025
  • Figure 15: Global Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Drug Eluting Stent Market, Sub-Segmentation Of Polymer-Based, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Drug Eluting Stent Market, Sub-Segmentation Of Polymer-Free, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Drug Eluting Stent Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Drug Eluting Stent Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global Drug Eluting Stent Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global Drug Eluting Stent Market - Company Scoring Matrix
  • Figure 98: Abbott Laboratories Financial Performance
  • Figure 99: Boston Scientific Corporation Financial Performance
  • Figure 100: Medtronic plc Financial Performance
  • Figure 101: Terumo Corporation Financial Performance
  • Figure 102: BIOTRONIK SE & Co KG Financial Performance
  • Figure 103: Global Drug Eluting Stent Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global Drug Eluting Stent Market, Competitive Dashboard
  • Figure 105: Global Drug Eluting Stent Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, Drug Eluting Stent Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Figure 107: Global, Drug Eluting Stent Market Size Gain ($ Billion), Segmentation By Drug, 2025 – 2030
  • Figure 108: Global, Drug Eluting Stent Market Size Gain ($ Billion), Segmentation By Scaffold, 2025 – 2030

Glaucoma Surgery Devices Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

Read More About Glaucoma Surgery Devices Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

Glucose Biosensors Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Read More About Glucose Biosensors Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Global GMP Cell Therapy Consumables Market Trends: Regional Breakdowns and Strategic Insights

Read More About Global GMP Cell Therapy Consumables Market Trends: Regional Breakdowns and Strategic Insights

Guidewires Outlook 2034: Key Drivers, Trends, and Market Frontiers

Read More About Guidewires Outlook 2034: Key Drivers, Trends, and Market Frontiers

Discover the latest insights, trends, and market numbers in the maternal and baby grade wipes market backed by expert analysis and data-driven projections.

Read More About Discover the latest insights, trends, and market numbers in the maternal and baby grade wipes market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical soap market backed by expert analysis and data-driven projections.

Read More About Discover the latest insights, trends, and market numbers in the medical soap market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the lichen planus market backed by expert analysis and data-driven projections.

Read More About Discover the latest insights, trends, and market numbers in the lichen planus market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical syringe drive systems market backed by expert analysis and data-driven projections.

Read More About Discover the latest insights, trends, and market numbers in the medical syringe drive systems market backed by expert analysis and data-driven projections.

Toasters Market Report 2026 - Global Outlook – By Product Type ( Pop-Up Toasters, Toaster Ovens, Conveyor Toasters), By Distribution channel ( Online, Offline), By End-User ( Residential, Commercial) – Market Size, Trend...

Soft Touch Polyurethane Coatings Market Report 2026 - Global Outlook – By Base Type (Water-Based, Solvent-Based), By End-Use (Automotive, Aerospace, Electrical And Electronic, Furniture, Other End-users), By Application ...

Bioabsorbable Stents Market Report 2026 - Global Outlook – By Product Type (Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents), By Absorption Rate (Slow- Absorption Stents, Fast- Absorption Stents), By...

Feed And Animal Nutrition Market Report 2026 - Global Outlook – By Product Type (Amino Acids, Vitamins, Minerals, Enzymes, Fish Oils And Nutrition Lipids, Eubiotics, Carotenoids, Other Product Types), By Species (Poultry...

Sharing Accommodation Market Report 2026 - Global Outlook – By Product (Economy Type, Comfortable Type, Boutique Type, Luxury Type, Other Products), By Booking Mode (Offline, Online And Platform-Based), By Application (T...

Intracranial Stents Market Report 2026 - Global Outlook – By Type (Self-Expanding Stents, Balloon-Expanding Stents), By Disease Indication (Brain Aneurysm, Intracranial Stenosis), By End-User (Hospitals, Ambulatory Surge...

Aerospace Engineering Services Outsourcing Market Report 2026 - Global Outlook – By Component (Software, Hardware ), By Service (Design And Engineering, Manufacturing Support, Security And Certification, After-Market Ser...

Frequently Asked Questions

The Drug Eluting Stent market was valued at $8.26 billion in 2025, increased to $8.94 billion in 2026, and is projected to reach $11.7 billion by 2030.

The global Drug Eluting Stent market is expected to grow at a CAGR of 6.9% from 2026 to 2035 to reach $11.7 billion by 2035.

Some Key Players in the Drug Eluting Stent market Include, Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Terumo Corporation, BIOTRONIK SE & Co KG, Biosensors International Group Ltd, MicroPort Scientific Corporation, Lepu Medical

Major trend in this market includes: Innovation In Advanced Drug-Eluting Coronary Stents. For further insights on this market. request a sample here

North America was the largest region in the drug-eluting stent market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting stent market report are Asia-Pacific, So

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us